Extension and structural variability of the antithrombin-binding sequence in heparin.
about
Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cellsA heparin-binding protein involved in inhibition of smooth-muscle cell proliferationHeparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formationGlycoarray Technologies: Deciphering Interactions from Proteins to Live Cell ResponsesCombined strong anion-exchange HPLC and PAGE approach for the purification of heparan sulphate oligosaccharidesGlycomics approaches for the bioassay and structural analysis of heparin/heparan sulphatesInteraction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin IIIFinding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesScreening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometryCarbohydrate cluster microarrays fabricated on three-dimensional dendrimeric platforms for functional glycomics exploration.A strategy for rapid sequencing of heparan sulfate and heparin saccharides.Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domains.Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum.Capillary electrophoretic study of small, highly sulfated, non-sugar molecules interacting with antithrombin.Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.Molecular organization of the interferon gamma-binding domain in heparan sulphate.Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide.Inhibition of leucocyte elastase by heparin and its derivatives.Basement-membrane heparan sulphate with high affinity for antithrombin synthesized by normal and transformed mouse mammary epithelial cells.Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entryGlycosaminoglycans and the regulation of blood coagulation.Interaction of heparin with synthetic antithrombin III peptide analogues.Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region.Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system.De novo design of self-assembling foldamers that inhibit heparin-protein interactions.Molecular organization of heparan sulphate from human skin fibroblasts.Functional role of the polysaccharide component of rabbit thrombomodulin proteoglycan. Effects on inactivation of thrombin by antithrombin, cleavage of fibrinogen by thrombin and thrombin-catalysed activation of factor V.Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII).Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structureBiological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.A fragment of antithrombin that binds both heparin and thrombin.Location of antithrombin-binding regions in rat skin heparin proteoglycansDegradation of heparin proteoglycan in cultured mouse mastocytoma cells.Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin.Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.Heparin: role in protein purification and substitution with animal-component free material
P2860
Q24528208-14180310-848F-43CE-8444-D340808A8A28Q24529516-7B403596-C0FC-441A-9E26-FC4AC96E33E8Q24650523-501A33DD-760A-4B86-880C-3ECC415F503AQ28073864-5914EC54-6492-40AC-863C-5D5D656B4DF5Q28348093-1557E13A-DFE0-4322-A0C0-08D1F01DF5A0Q30437948-3C092749-E8DC-458A-A56F-513C319F3125Q31051235-CF22540C-E817-438F-95E5-B5196122011BQ33246009-007B77A2-49E0-4B20-B223-7CDB98231775Q33318943-B0512919-8B4D-4C96-B094-9D751870CE3AQ33399576-CC63F506-59D6-4F0D-9788-3F6ABD4439BFQ33546538-402BBCED-F8A9-41B2-B9B6-FFF460A975E2Q33583964-2C55314D-FAEF-4770-A4A6-081049308D75Q35059120-6A11EAB4-FEA3-4413-BB54-B85A01DD695FQ35723932-6964CB1A-7E10-4152-BF78-F666B16AB5CEQ36797422-B0A5669C-6C73-4038-B228-CEC08F02A566Q37371255-D6F3327D-A5F6-45B9-9BBD-6B41C4AC3FD0Q37461866-11F37DC6-8833-4088-BF37-84589D1DF1D9Q38292110-2AA9165D-CD49-4431-9BAB-F9BE22671699Q38293432-6AE45D8A-A4FE-47C6-B680-18F18968FA4FQ38347125-06961796-2F75-4D2C-A932-6F1E40CE0F6EQ38348387-F0A41929-E679-40A4-8F12-0A65B16DE1FBQ39874536-0AFC0D1F-E160-436A-ACA6-1963B3BCBC2AQ40851193-91D0F598-C769-49D1-9C5F-A713D488CFA0Q41763091-D17D208E-712E-496A-8296-775B2AE62842Q41777711-79D8D9B8-9801-4113-BAFA-17BE270148DAQ41814747-A8BFE895-ACC7-4A70-90A9-593A2ADDEBD7Q41828921-3437FF48-D380-49F0-AEB9-62101D19B05FQ41851118-372B9ABD-74C2-4F6E-87F6-CBE68934919FQ41975008-31590FD8-DB38-454C-8830-4FD53495F342Q42104389-45454F8D-3574-437E-AF3C-0EC6E2C930B0Q42160055-6071C61A-B4CA-469E-B9BB-7994F4CBCD99Q42161980-C4AAC451-B99F-4C7A-8B46-8EF361CC5345Q42165347-1B08C92C-4127-470E-A5ED-7390FE4DECB3Q42854196-BC3ABB33-D598-4C90-AE40-4D42FE1BEAF8Q42855068-6D40F816-5C63-49B7-AF80-A147CEFCB3CDQ42856709-3E8B6CF3-5590-4AFA-9B56-FBEDF1C4AF18Q42857980-30AC4B5A-1190-4FCE-8498-0F5BC120568EQ42970671-A64CCF11-EF59-461D-B51B-A53EBC65DF66Q58792047-CBAFDF0E-46A9-4E27-AEEA-E63E03EB92E8
P2860
Extension and structural variability of the antithrombin-binding sequence in heparin.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Extension and structural variability of the antithrombin-binding sequence in heparin.
@en
type
label
Extension and structural variability of the antithrombin-binding sequence in heparin.
@en
prefLabel
Extension and structural variability of the antithrombin-binding sequence in heparin.
@en
P2093
P1476
Extension and structural variability of the antithrombin-binding sequence in heparin
@en
P2093
Bäckström G
Nordling K
Riesenfeld J
Thunberg L
P304
12368-12376
P407
P50
P577
1984-10-01T00:00:00Z